BioMarin shares settle after take out speculation

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) jumped 11% to a pre-market high of $86.25, ahead of its 52-week high of $80.67, on rumors that Roche (SIX:ROG; OTCQX:RHHBY) is considering a bid to acquire the biotech. However, BioMarin shares closed up only $0.95 to $78.44 on the day after reports surfaced that Roche denied raising debt in preparation for a bid for BioMarin. BioMarin and Roche said they do not comment on rumors. ...